logo

For the Inventor, By the Inventor

Hong Kong, China

Man Fung Yuen

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: The University of Hong Kong, Versitech, Inc., The Education University of Hong Kong. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Man Fung Yuen. Retrieved from https://idiyas.com/inventor/man-fung-yuen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:

goldMedal2 out of 376 
 
The University of Hong Kong
 patents
silverMedal2 out of 144 
 
Versitech, Inc.
 patents
bronzeMedal1 out of 13 
 
The Education University of Hong Kong
 patents
where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12694525 - Generative adversarial network-based lossless image compression model for cross-sectional imaging (2026-07-28),
2. 12421562 - Fecal microbial biomarkers for non-alcoholic fatty liver disease (2025-09-23),
3. 12322151 - DA-BD-LSTM-dense-UNet for liver lesion segmentation (2025-06-03),
4. 9879330 - Hepatitis B variants with reduced sensitivity to therapeutic compounds, their detection and uses thereof (2018-01-30),

Title: Man Fung Yuen: Innovator in Liver Disease Diagnostics and Treatment

Introduction

Man Fung Yuen is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in the area of liver diseases. With a total of 4 patents, Yuen is recognized for his innovative approaches to diagnosing and treating non-alcoholic fatty liver disease (NAFLD).

Latest Patents

Yuen's latest patents include groundbreaking work on fecal microbial biomarkers for non-alcoholic fatty liver disease. This patent discloses microbial biomarkers and methods for accurate non-invasive diagnosis of NAFLD in subjects. The microbial biomarkers include various strains and subspecies, and the methods involve measuring the abundance or copy number of these biomarkers in samples such as bodily fluids, mucus, or stool. Additionally, he has developed a patent titled "DA-BD-LSTM-dense-UNet for liver lesion segmentation," which utilizes artificial intelligence for the detection and characterization of liver cancers.

Career Highlights

Man Fung Yuen is affiliated with The University of Hong Kong, where he continues to advance research in liver disease diagnostics. His work has garnered attention for its potential to improve patient outcomes through innovative diagnostic methods.

Collaborations

Yuen collaborates with notable colleagues, including Philip Leung Ho Yu and Keith Chiu, contributing to a dynamic research environment focused on liver health.

Conclusion

Man Fung Yuen's contributions to the field of liver disease diagnostics and treatment highlight his role as an influential inventor. His innovative patents pave the way for advancements in non-invasive diagnostic methods and artificial intelligence applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…